LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 62.29 | 84.90 | 859 | 7934 | 0.1083 | 0.4241 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 62.29 | 84.90 | 897 | 7934 | 0.1131 | 0.4335 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 62.29 | 84.90 | 54 | 7934 | 0.0068 | -0.0668 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 62.29 | 84.90 | 1186 | 7934 | 0.1495 | 0.4960 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 63.99 | 84.90 | 890 | 8212 | 0.1084 | 0.4280 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 63.99 | 84.90 | 924 | 8212 | 0.1125 | 0.4361 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 63.99 | 84.90 | 74 | 8212 | 0.0090 | -0.0206 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 63.99 | 84.90 | 1140 | 8212 | 0.1388 | 0.4826 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 65.70 | 84.90 | 830 | 8484 | 0.0978 | 0.4095 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 65.70 | 84.90 | 867 | 8484 | 0.1022 | 0.4188 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 65.70 | 84.90 | 69 | 8484 | 0.0081 | -0.0307 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 65.70 | 84.90 | 1182 | 8484 | 0.1393 | 0.4865 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 67.41 | 84.90 | 835 | 8766 | 0.0953 | 0.4073 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 67.41 | 84.90 | 865 | 8766 | 0.0987 | 0.4148 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 67.41 | 84.90 | 87 | 8766 | 0.0099 | 0.0037 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 67.41 | 84.90 | 1242 | 8766 | 0.1417 | 0.4934 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 69.11 | 84.90 | 942 | 8988 | 0.1048 | 0.4302 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 69.11 | 84.90 | 998 | 8988 | 0.1110 | 0.4425 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 69.11 | 84.90 | 97 | 8988 | 0.0108 | 0.0200 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 69.11 | 84.90 | 1291 | 8988 | 0.1436 | 0.4988 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.81 | 84.90 | 885 | 9132 | 0.0969 | 0.4153 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.81 | 84.90 | 928 | 9132 | 0.1016 | 0.4253 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.81 | 84.90 | 102 | 9132 | 0.0112 | 0.0276 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.81 | 84.90 | 1189 | 9132 | 0.1302 | 0.4786 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 72.52 | 84.90 | 913 | 9214 | 0.0991 | 0.4209 | MN20160318_Q02 | E08 |